Pathology
$496,287U19FY2015AINIH
Beth Israel Deaconess Medical Center, Boston MA
Investigators
Linked publications & trials
Paper 32256496Paper 31890736Paper 30850342Paper 30629920Paper 30087334Paper 30082858Paper 29867228Paper 29237759Paper 28580942Paper 28505602Paper 28457610Paper 28228277Paper 28133810Paper 27540005Paper 27497036Paper 27492477Paper 27419172Paper 27355570Paper 27268856Paper 27085913Paper 26864031Paper 26849216Paper 26444083Paper 26248318Paper 26193080Paper 26138104Paper 25768938Paper 25688559Paper 25657614Paper 25473043Paper 25445329Paper 25424923Paper 25416935Paper 25296195Paper 25282469Paper 25210178Paper 25135832Paper 25042999Paper 25013067Paper 24899503Paper 24820481Paper 24556505Paper 24429370Paper 24316643Paper 24283223Paper 24257612Paper 24243013Paper 24172905Paper 24025770Paper 23925001Paper 23772627Paper 23468494Paper 23408608Paper 23063120Paper 22896617Paper 22811531Paper 22787208Paper 22761379Paper 22593160Paper 22217938Paper 22133509
Abstract
While there has been progress in developing an AIDS vaccine, there is as yet no truly effective vaccine to prevent HIV-1 transmission. This project will provide tissue analysis technologies such as in situ hybridization and tetramer staining, immunochemistry, and combinations thereof to investigators who will use these methods to assess impact and mechanisms of vaccine strategies on the natural history of vaginal transmission and acute systemic infection in the SlV/SHIV-rhesus macaque animal model.
View original record on NIH RePORTER →